Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

8.1%

3 terminated out of 37 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

19%

7 trials in Phase 3/4

Results Transparency

24%

5 of 21 completed with results

Key Signals

5 with results88% success

Data Visualizations

Phase Distribution

28Total
Not Applicable (19)
P 2 (2)
P 3 (2)
P 4 (5)

Trial Status

Completed21
Unknown8
Withdrawn3
Terminated3
Recruiting1
Not Yet Recruiting1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 21 completed trials

Clinical Trials (37)

Showing 20 of 20 trials
NCT07316504Not ApplicableRecruiting

Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions

NCT06979284Not ApplicableNot Yet Recruiting

Intravascular Ultrasound for Peripheral Artery Disease Revascularization

NCT03332264Not ApplicableCompleted

Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions

NCT04514406Terminated

APERTO CVS PMCF Study

NCT02621489Phase 4Completed

Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects

NCT01065532Not ApplicableCompletedPrimary

SEDUCE OCT Study in Coronary Artery rEstenosis:an Optical Coherence Tomography (OCT) Study

NCT01735825Not ApplicableCompletedPrimary

Treatment of Coronary In-Stent Restenosis

NCT00493597Completed

Blood Endothelium Progenitor Cells and Dendritic Cells as Predictive Biomarkers of In-stent Restenosis

NCT05451368Unknown

Neointimal Features in Patients With Restenosis of Calcified Lesions

NCT02649946Not ApplicableCompleted

Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft

NCT03141580Not ApplicableCompleted

Long-term Follow-up NIRS-IVUS Imaging of Pre-existing Carotid Stents

NCT02790606Not ApplicableCompleted

Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA)

NCT01970579Phase 3Completed

Clinical Trial on Peripheral Arteries Treated With SeQuent® Please P Paclitaxel Coated Balloon Catheter

NCT01722877Not ApplicableCompletedPrimary

JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions

NCT03613337Unknown

Effect of Smoking Status and Genetic Risk Factors on Restenosis and Efficacy of Clopidogrel After de Novo Percutaneous Coronary Intervention

NCT01861860Not ApplicableCompleted

OPtimized Stenting Using Intravascular Ultrasound(IVUS) in Long lEsion: Rationale for Simplified criteriA

NCT02063672Not ApplicableCompleted

Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

NCT03858764Withdrawn

Local Paclitaxel Delivery to Prevent Restenosis in Peripheral Arterial Disease

NCT02809248Not ApplicableWithdrawnPrimary

The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study)

NCT03146221Not ApplicableWithdrawnPrimary

Search for Restenosis Markers in Lower Limb Arteritis

Scroll to load more

Research Network

Activity Timeline